 Home > Active Ingredient News > Study of Nervous System > Neurology: During the COVID-19 pandemic, the number of hospitalizations and thrombolytic treatments for stroke globally decreased significantly

Neurology: During the COVID-19 pandemic, the number of hospitalizations and thrombolytic treatments for stroke globally decreased significantly

 Last Update: 2021-04-14
 Source: Internet
 Author: User

Tags

2 4 ester

new world inn

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The new crown pandemic has reconstructed the care of critically ill patients with COVID-19 in the global medical system .

COVID-19

According to reports, SARS-CoV-2 and its related neurological manifestations include ischemic, hemorrhagic, and cerebral venous stroke.

Infection Thrombosis Stroke Immunity

The heterogeneity of stroke subtypes related to the new coronavirus suggests that the pathogenesis of stroke is different, including endothelial dysfunction, thrombotic dysfunction, and non-specific effects of inflammation.

Although reports of COVID-19 thromboembolic events have increased, the number of acute stroke treatment initiation, stroke hospitalizations, and mechanical thrombectomy has declined at the local, regional, and national levels.

Blood vessel

With this, Raul G Nogueira and others of Emory University conducted a cross-sectional, observational, and retrospective study integrating 6 continents, 70 countries and 457 stroke centers.

Through the integration of relevant global data, a total of 91,373 stroke patients were admitted to the hospital.

Recovery of stroke hospitalizations (9.

The significance of this meta-analysis study is that the COVID-19 pandemic is related to the overall decline in stroke hospitalization and IVT treatment.

The COVID-19 pandemic is related to the overall decline in stroke hospitalization and IVT treatment.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pregabalin (CNS)

CAS No.: 148553-50-8

Pharmacy Grade

$1/KG FOB

Primidone CAS125-33-7

CAS No.: 125-33-7

Pharmaceutical Grade

$100/KG EXW

API Clomipramine HCl

CAS No.: 17321-77-6

Pharmacy Grade

$40-50/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.